BMRN

Q: What is the price of BioMarin Pharmaceutical (BMRN) today?

The price of BioMarin Pharmaceutical (BMRN) today is US$ 54,55, with a variation of -22.05% compared to the last year. The price of BioMarin Pharmaceutical (BMRN) started the year trading around US$ 65,73 and today it is at US$ 54,55. Follow the real-time price chart, the historical price of BioMarin Pharmaceutical (BMRN), and stock data from Ibovespa and international markets.

Q: When does BioMarin Pharmaceutical (BMRN) pay dividends?

BioMarin Pharmaceutical (BMRN) não distribuiu dividendos no último ano.

Q: BioMarin Pharmaceutical (BMRN) is it worth it?

Currently, BioMarin Pharmaceutical (BMRN) is priced at US$ 54,55, with a P/E of 15,57%, representing a deviation of 6,63% from its historical average P/E. In the last year, the stock showed a variation of -22.05% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -22,05%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of BioMarin Pharmaceutical (BMRN)?

Investing in stocks of BioMarin Pharmaceutical (BMRN) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of BioMarin Pharmaceutical (BMRN) yield today?

The yield of BioMarin Pharmaceutical (BMRN) was 2,13% in the last month, -22,05% in the last year and -29,05% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of BioMarin Pharmaceutical (BMRN) today, the total investment would be US$ 5.455,00, based on the current price of US$ 54,55.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 4.252,17In 5 years: US$ 3.870,32In 10 years: 2.687,68It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

BioMarin Pharmaceutical Inc.

Price

US$ 54,55

variation (12m)

-22,05%

p/l

15,57

p/vp

1,70

DIVIDEND YIELD

0,00%

price BMRN

BVMF

BMRN

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of BMRN

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

2,13%

3 months

-7,56%

1 year

-22,05%

2 years

-34,55%

5 years

-29,05%

10 years

-50,73%

Indicators BMRN

check out the fundamentals of BioMarin Pharmaceutical shares

P/E

15,57

Sector: -3,77 Industry: -3,77

P/SALES RATIO (PSR)

3,34

Sector: -3,52 Industry: -3,52

P/BV

1,70

Sector: 1,91 Industry: 1,91

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

8,81%

Sector: -64,24% Industry: -64,24%

ROE

10,90%

Sector: -69,36% Industry: -69,36%

ROIC

16,90%

Sector: -2.091,13% Industry: -2.091,13%

NET MARGIN

21,45%

Sector: -43,38% Industry: -43,38%

GROSS MARGIN

79,56%

Sector: 39,75% Industry: 39,75%

OPERATING MARGIN

25,33%

Sector: -42,61% Industry: -42,61%

P/EBITDA

10,95

Sector: -3,66 Industry: -3,66

P/EBIT

12,02

Sector: -3,95 Industry: -3,95

P/ASSET

1,37

Sector: 1,41 Industry: 1,41

BVPS

31,39

Sector: 1,83 Industry: 1,83

EPS

3,42

Sector: -2,14 Industry: -2,14

EQUITY / ASSETS

0,81

Sector: 0,41 Industry: 0,41

CAGR REVENUES 5 YEARS

10,49%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

-5,10%

Sector: - Industry: -

FAIR PRICE OF BioMarin Pharmaceutical ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 54,55

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-9,90%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

BMRN indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	18,40	0,00	0,00%	2,65%	US$ 462,14 B	27,26%
PFE	12,73	1,54	12,08%	7,10%	US$ 136,89 B	16,84%
ABBV	107,86	-2.941,16	-2.726,81%	2,82%	US$ 405,88 B	6,45%
NVO	14,80	9,31	62,86%	3,10%	US$ 241,78 B	35,63%
MRK	12,97	4,34	33,44%	3,82%	US$ 212,82 B	25,79%
AZN	31,65	5,86	18,51%	1,85%	US$ 262,54 B	14,68%
BMY	17,35	5,01	28,87%	5,72%	US$ 87,58 B	10,58%
GILD	24,23	7,80	32,21%	2,56%	US$ 152,90 B	21,87%
ZTS	24,54	12,88	52,48%	1,34%	US$ 64,11 B	27,83%
HALO	14,55	24,37	167,47%	0,00%	US$ 8,11 B	47,28%
REGN	13,61	2,03	14,89%	0,46%	US$ 60,70 B	31,37%
AMGN	24,29	21,64	89,11%	3,14%	US$ 160,76 B	18,96%
VRTX	29,45	6,24	21,18%	0,00%	US$ 107,12 B	31,86%
MCK	31,05	-113,85	-366,63%	0,38%	US$ 98,25 B	0,84%
CAH	23,85	-14,13	-59,26%	1,30%	US$ 37,23 B	0,70%
ADMA	16,56	8,69	52,45%	0,00%	US$ 3,46 B	44,06%
BIIB	13,73	1,19	8,68%	0,00%	US$ 21,02 B	15,31%

comparison of BMRN with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History BMRN

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY BioMarin Pharmaceutical

BioMarin Pharmaceutical Inc.

Average user rating I10

4.0 (3 people)

Estados Unidos

29 years

Foundation: 1996

1999

Year of debut on the stock exchange - 26 years

3.059

Employees

The Company BioMarin Pharmaceutical Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 10,23 Billions, having a net worth of $ 6,03 Billions.

With a total of 3.059 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 3,06 Billions, which generated a profit in the amount of $ 657,24 Milhões.

As for its main indicators, the Company has a P/E ratio of 15,57, a P/BV ratio of 1,70 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker BMRN.

Market value

US$ 10,23 Billions

Net worth

US$ 6,03 Billions

US$ 6.027.110.000,00

Assets

US$ 7,46 Billions

US$ 7.456.340.000,00

Total Number of Shares

192,00 Milhões

192.000.000

Average Daily Trading Volume

US$ 2,05 Milhões

US$ 2.049.460,60

Sector

Health Care

Industry

Biotechnology

BMRN

BMRN revenue and profits

BMRN results

DRAG THE FRAME TO SEE MORE DATA

BMRN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 792,97 57,73% (12M)

P/L

31,05

0,38%

ROE

-366,63%

P/VP

-113,85

CAH - Cardinal Health

US$ 159,16 43,94% (12M)

P/L

23,85

1,30%

ROE

-59,26%

P/VP

-14,13

JNJ - Johnson & Johnson

US$ 192,47 22,22% (12M)

P/L

18,40

2,65%

ROE

0,00%

P/VP

0,00

MRK - Merck & Co.

US$ 87,18 --14,61% (12M)

P/L

12,97

3,82%

ROE

33,44%

P/VP

4,34

ABBV - AbbVie

US$ 228,25 25,55% (12M)

P/L

107,86

2,82%

ROE

-2.726,81%

P/VP

-2.941,16

PFE - Pfizer

US$ 24,67 --5,50% (12M)

P/L

12,73

7,10%

ROE

12,08%

P/VP

1,54

AZN - AstraZeneca

US$ 83,40 12,23% (12M)

P/L

31,65

1,85%

ROE

18,51%

P/VP

5,86

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 792,97 57,73% (12 M)

P/L

31,05

0,38%

ROE

-366,63%

P/VP

-113,85

CAH - Cardinal Health

US$ 159,16 43,94% (12 M)

P/L

23,85

1,30%

ROE

-59,26%

P/VP

-14,13

JNJ - Johnson & Johnson

US$ 192,47 22,22% (12 M)

P/L

18,40

2,65%

ROE

0,00%

P/VP

0,00

MRK - Merck & Co.

US$ 87,18 --14,61% (12 M)

P/L

12,97

3,82%

ROE

33,44%

P/VP

4,34

ABBV - AbbVie

US$ 228,25 25,55% (12 M)

P/L

107,86

2,82%

ROE

-2.726,81%

P/VP

-2.941,16

PFE - Pfizer

US$ 24,67 --5,50% (12 M)

P/L

12,73

7,10%

ROE

12,08%

P/VP

1,54

AZN - AstraZeneca

US$ 83,40 12,23% (12 M)

P/L

31,65

1,85%

ROE

18,51%

P/VP

5,86

Frequently Asked Questions

What is the price of BioMarin Pharmaceutical (BMRN) today?

The price of BioMarin Pharmaceutical (BMRN) today is US$ 54,55, with a variation of -22.05% compared to the last year. The price of BioMarin Pharmaceutical (BMRN) started the year trading around US$ 65,73 and today it is at US$ 54,55. Follow the real-time price chart, the historical price of BioMarin Pharmaceutical (BMRN), and stock data from Ibovespa and international markets.

When does BioMarin Pharmaceutical (BMRN) pay dividends?

BioMarin Pharmaceutical (BMRN) não distribuiu dividendos no último ano.

BioMarin Pharmaceutical (BMRN) is it worth it?

Currently, BioMarin Pharmaceutical (BMRN) is priced at US$ 54,55, with a P/E of 15,57%, representing a deviation of 6,63% from its historical average P/E. In the last year, the stock showed a variation of -22.05% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -22,05%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of BioMarin Pharmaceutical (BMRN)?

Investing in stocks of BioMarin Pharmaceutical (BMRN) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of BioMarin Pharmaceutical (BMRN) yield today?

The yield of BioMarin Pharmaceutical (BMRN) was 2,13% in the last month, -22,05% in the last year and -29,05% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 stocks of BioMarin Pharmaceutical (BMRN) today, the total investment would be US$ 5.455,00, based on the current price of US$ 54,55.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 4.252,17
In 5 years: US$ 3.870,32
In 10 years: 2.687,68

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

BMRN

BioMarin Pharmaceutical Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of BMRN

check out the fundamentals of BioMarin Pharmaceutical shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY BioMarin Pharmaceutical

BioMarin Pharmaceutical Inc.

Estados Unidos

29 years

1999

3.059

PROFIT X PRICE BMRN

BMRN results

BMRN cash flow

evolution of assets - BMRN

BMRN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

Frequently Asked Questions